妇科千金片联合阿奇霉素治疗急性盆腔炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.

基金项目:


Clinical Study on Combination Use of Fuke Qianjin Tablets and Azithromycin for Acute Pelvic Inflammatory Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察妇科千金片联合阿奇霉素治疗急性盆腔炎的疗效及对子宫血流动力学、免疫学指标的 影响。方法:选取2020年11月—2022年11月永康市第二人民医院收治的70例急性盆腔炎患者,按随机数字 表法分为试验组及对照组各5例。对照组采用阿奇霉素治疗,试验组在对照组基础上服用妇科千金片治疗。 比较2组临床疗效及不良反应发生率,比较2组治疗前后McCormack量表评分、炎性包块、盆腔积液、子宫血 流动力学指标[阻力指数(RI)、搏动指数(PI)、平均血流速度(Vmin)]、免疫学指标值的变化。结果:试 验组临床疗效总有效率为94.29% (/5),对照组为77.14% (27/5),2组比较,差异有统计学意义(P< 0.05)。治疗后, 2 组McCormack 量表评分、炎性包块、盆腔积液均较治疗前减小(P<0.05), 试验组 McCormack量表评分、炎性包块、盆腔积液均小于对照组(P<0.05)。治疗后,2组RI、PI值均较治疗前下 降(P<0.05),Vmin值均较治疗前升高(P<0.05);试验组RI、PI值均低于对照组(P<0.05),Vmin值高于 对照组(P<0.05)。治疗后,2组CD4+水平、CD4+/CD8+比值均较治疗前上升(P<0.05),CD8+水平均较治疗前 下降(P<0.05);试验组CD4+水平、CD4+/CD8+比值均高于对照组,CD8+水平低于对照组(P<0.05)。试验组 不良反应发生率为5.71% (12/5),对照组不良反应发生率为8.57% (/5),2组不良反应发生率比较,差异 无统计学意义(P>0.05)。结论:妇科千金片联合阿奇霉素治疗急性盆腔炎效果较好,可改善患者子宫血流动 力学指标,提高免疫功能,安全性高。

    Abstract:

    Abstract: Objective: To observe the curative effect of the combination use of Fuke Qianjin Tablets and Azithromycin on acute pelvic inflammatory disease and its effect on uterine hemodynamics and immunology indexes. Methods: A total of 70 patients with acute pelvic inflammatory disease admitted to Yongkang No.2 People Hospital from November 2020 to November 2022 were selected and divided into the trial group and the control group according to the random number table method,with 5 cases in each group. The control group was treated with Azithromycin,and the trial group was additionally treated with Fuke Qianjin Tablets based on the treatment of the control group. The clinical effects and incidence of adverse reactions,and the changes of scores of McCormack Scale,inflammatory mass, pelvic effusion, uterine hemodynamics indexes [resistance index (RI), pulsatility index (PI) and mean blood flow velocity (Vmin)] and immunology indexes before and after treatment were compared between the two groups. Results: The total effective rate was 94.29%(/5) in the trial group and 77.14%(27/5) in the control group,the difference being significant (P<0.05). After treatment,the scores of McCormack Scale,inflammatory mass and pelvic effusion in the two groups were reduced when compared with those before treatment (P<0.05),and the score of McCormack scale, inflammatory mass and pelvic effusion in the trial group were less than those in the control group (P<0.05). After treatment, the values of RI and PI in the two groups were decreased when compared with those before treatment (P<0.05),and the Vmin values were elevated when compared with those before treatment (P<0.05);the values of RI and PI in the trial group were lower than those in the control group (P<0.05),and the Vmin value was higher than that in the control group (P<0.05). After treatment,the CD4+ levels and CD4+/CD8+ ratio in the two groups were up-regulated when compared with those before treatment (P<0.05), and the CD8+ levels were down-regulated when compared with those before treatment (P<0.05); the CD4+ level and CD4+/CD8+ ratio in the trial group were higher than those in the control group, and the CD8+ level was lower than that in the control group (P<0.05). The incidence of adverse reactions was 5.71%(2/5) in the trial group and 8.57%(/5) in the control group,there being no significance in the difference (P>0.05). Conclusion:The combination use of Fuke Qianjin Tablets and Azithromycin has a great curative effect on acute pelvic inflammatory disease, which can improve the urine hemodynamics indexes and the immune function with great safety.

    参考文献
    相似文献
    引证文献
引用本文

周金玲,孙成艳,徐晓聪.妇科千金片联合阿奇霉素治疗急性盆腔炎临床研究[J].新中医,2025,57(3):95-99

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-02-22
  • 出版日期:
文章二维码